✦ LIBER ✦

Rivastigmine edges out donepezil in Alzheimer's disease

Book ID: 120852603
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2005
Weight: 121 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200515030-00029

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Donepezil vs rivastigmine in Alzheimer's

Donepezil vs rivastigmine in Alzheimer's disease − same benefits, different downsides

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 157 KB

Donepezil is better tolerated than rivas

Donepezil is better tolerated than rivastigmine in mild-to-moderate Alzheimer's disease,

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Rivastigmine effective in Alzheimer’s di

Rivastigmine effective in Alzheimer’s disease

📂 Article 📅 1999 🏛 Adis International Limited (now part of Wolters Kl ⚖ 280 KB

Rivastigmin beneficial in Alzheimer’s di

Rivastigmin beneficial in Alzheimer’s disease

📂 Article 📅 1997 🏛 Adis International Limited (now part of Wolters Kl ⚖ 187 KB

Rivastigmine for Alzheimer’s disease

✍ Desai, Abhilash K; Grossberg, George T 📂 Article 📅 2005 🏛 Expert Reviews 🌐 English ⚖ 288 KB

Switching cholinesterase inhibitor thera

Switching cholinesterase inhibitor therapy in Alzheimer's disease—donepezil to rivastigmine, is it worth it?

✍ Roger Bullock; Claire Connolly 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 1 views

Switching from donepezil to rivastigmine was bene®cial in cognitive and global terms in 55.0% of the patients with Alzheimer's disease studied. \* Side-effects on donepezil and rivastigmine were independent of one another. \* It may be possible to extend the positive effects that cholinesterase inhi